Taken together, these data suggest that OPN binding with CD44 in gliomas initiates a stem-promoting cascade that begins with the cleavage of CD44 ICD and results in the transcription of stem cell genes mediated by HIF-2α and CBP/p300. The gene discussed is CD44; the disease is central nervous system cancer.